These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28592872)

  • 81. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Lin YH; Yang-Yen HF
    J Biol Chem; 2001 Dec; 276(49):46024-30. PubMed ID: 11590166
    [TBL] [Abstract][Full Text] [Related]  

  • 83. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.
    Ma M; Wang X; Chen X; Cai R; Chen F; Dong W; Yang G; Pang W
    RNA Biol; 2017 Mar; 14(3):347-360. PubMed ID: 28085550
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Negative Immune Regulator TIPE2 Promotes M2 Macrophage Differentiation through the Activation of PI3K-AKT Signaling Pathway.
    Liu R; Fan T; Geng W; Chen YH; Ruan Q; Zhang C
    PLoS One; 2017; 12(1):e0170666. PubMed ID: 28122045
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Regulation and importance of the PI3K/Akt/mTOR signaling pathway in hematologic malignancies.
    Kawauchi K; Ogasawara T; Yasuyama M; Otsuka K; Yamada O
    Anticancer Agents Med Chem; 2009 Nov; 9(9):1024-38. PubMed ID: 19663778
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy.
    Wu YT; Tan HL; Huang Q; Ong CN; Shen HM
    Autophagy; 2009 Aug; 5(6):824-34. PubMed ID: 19556857
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Insulin and IGFs enhance hepatocyte differentiation from human embryonic stem cells via the PI3K/AKT pathway.
    Magner NL; Jung Y; Wu J; Nolta JA; Zern MA; Zhou P
    Stem Cells; 2013 Oct; 31(10):2095-103. PubMed ID: 23836547
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pro-angiogenesis effect and transcriptome profile of Shuxinyin formula in zebrafish.
    Zhou ZY; Xiao Y; Zhao WR; Zhang J; Shi WT; Ma ZL; Ye Q; Chen XL; Tang N; Tang JY
    Phytomedicine; 2019 Dec; 65():153083. PubMed ID: 31600690
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with pancreatic ductal adenocarcinoma.
    Xie P; Tan SY; Li HF; Tang HD; Zhou JH
    J Gene Med; 2024 Jan; 26(1):e3570. PubMed ID: 37482968
    [TBL] [Abstract][Full Text] [Related]  

  • 90. GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K/AKT signaling.
    Yue J; Zhao X
    Biomed Pharmacother; 2020 Feb; 122():109701. PubMed ID: 31918274
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 92. PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells.
    Hunzicker-Dunn ME; Lopez-Biladeau B; Law NC; Fiedler SE; Carr DW; Maizels ET
    Proc Natl Acad Sci U S A; 2012 Oct; 109(44):E2979-88. PubMed ID: 23045700
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The pharmacological effects of Berberine and its therapeutic potential in different diseases: Role of the phosphatidylinositol 3-kinase/AKT signaling pathway.
    Khezri MR; Mohammadipanah S; Ghasemnejad-Berenji M
    Phytother Res; 2024 Jan; 38(1):349-367. PubMed ID: 37922566
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Activated AKT/PKB signaling in C. elegans uncouples temporally distinct outputs of DAF-2/insulin-like signaling.
    Gami MS; Iser WB; Hanselman KB; Wolkow CA
    BMC Dev Biol; 2006 Oct; 6():45. PubMed ID: 17020605
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Exosome-Depleted Excretory-Secretory Products of the Fourth-Stage Larval
    Wan S; Sun X; Tang W; Wang L; Wu Z; Sun X
    Front Immunol; 2021; 12():685984. PubMed ID: 34367145
    [No Abstract]   [Full Text] [Related]  

  • 97. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
    Lee JE; Lim MS; Park JH; Park CH; Koh HC
    Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations.
    Dubrovska A; Kim S; Salamone RJ; Walker JR; Maira SM; García-Echeverría C; Schultz PG; Reddy VA
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):268-73. PubMed ID: 19116269
    [TBL] [Abstract][Full Text] [Related]  

  • 99. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
    Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
    J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
    Costa C; Pereira S; Lima L; Peixoto A; Fernandes E; Neves D; Neves M; Gaiteiro C; Tavares A; Gil da Costa RM; Cruz R; Amaro T; Oliveira PA; Ferreira JA; Santos LL
    PLoS One; 2015; 10(11):e0141253. PubMed ID: 26569621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.